As a spin-off of the Institute of Bacteriology, Mycology and Hygiene (IBMH), a university institute which is internationally recognised for its research on mycoplasmas, Mycosafe is well-positioned to become a mycoplasma testing service center and developer of new mycoplasma testing assays of the future.

In comparison to other universities in Austria, the establishment of spin-off companies on its campus which are independent and majority-owned privately is a relatively new development at the University of Veterinary Medicine Vienna (VUW)

During the past years, however, there have been greater attempts to encourage academic-commerical partnerships on the VUW campus. Within the VUW environment, Mycosafe was established as the second spin-off company having its roots in a university institute.

Thus, the founding of Mycosafe, having its strength in the provision of quality control mycoplasma testing services and related research and development, contributed to the creation of a business biotechnology cluster on the VUW campus, which has been long associated with successful veterinary and medical research. Biotechnology and related areas now follow this tradition and continue the success story of the VUW as a research and business parc center.

The campus of the VUW is an ideal environment for new companies and offers excellent opportunities for attracting research talent and for new spin-off and start-up companies to take root. However, the future potential of the VUW as a location for new companies will also depend on the general conditions offered. Thus, the success of spin-off companies on the VUW campus does not depend uniquely on their scientific and financial competence, the social and political environment also plays an active role.